Latest News and Press Releases

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Limassol, Cyprus, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MSBforSale.com, a global leader in Money Service Business (MSB) licensing, compliance support, and crypto infrastructure solutions, today...

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company...

PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with...

TI has licensed Weebit ReRAM. The advanced NVM IP will be integrated into TI’s advanced process nodes for embedded processing semiconductors.

MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it has entered into an exclusive agreement with Regen Lab USA LLC to...

ADEIA AND DISNEY ENTER INTO LONG-TERM MEDIA IP LICENSE AGREEMENT

Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, long-acting bispecific antibody with best-in-disease potential in respiratory and dermatologyWIN027 blocks...

Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent...